Results 81 to 90 of about 49,041 (261)

Emergent lineages of mumps virus suggest the need for a polyvalent vaccine

open access: yesInternational Journal of Infectious Diseases, 2018
Mumps outbreaks among vaccinated patients have become increasingly common in recent years. While there are multiple conditions driving this re-emergence, convention has suggested that these outbreaks are associated with waning immunity rather than ...
Meghan May   +2 more
doaj   +1 more source

The Update, February 13, 2012 [PDF]

open access: yes, 2012
The Update is a bi-weekly web newsletter published by the Iowa Department of Public Health's Bureau of Family Health. It is posted the second and fourth week of every month, and provides useful job resource information for departmental health care ...

core  

Protein Target Highlights in CASP16: Insights From the Structure Providers

open access: yesProteins: Structure, Function, and Bioinformatics, Volume 94, Issue 1, Page 25-50, January 2026.
ABSTRACT This article presents an in‐depth analysis of selected CASP16 targets, with a focus on their biological and functional significance. The authors highlight the most relevant features of the target proteins and discuss how well these were reproduced in the submitted predictions.
Leila T. Alexander   +34 more
wiley   +1 more source

Entry, Replication, Immune Evasion, and Neurotoxicity of Synthetically Engineered Bat-Borne Mumps Virus

open access: yesCell Reports, 2018
Summary: Bats harbor a plethora of viruses with an unknown zoonotic potential. In-depth functional characterization of such viruses is often hampered by a lack of virus isolates.
Nadine Krüger   +13 more
doaj   +1 more source

Comparative Efficacy and Safety of Intralesional MMR Vaccine and Vitamin D3 in Managing Nongenital Warts: A Systematic Review and Meta‐Analysis

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Cutaneous warts are common benign lesions caused by human papillomavirus and often resist conventional treatments. Intralesional immunotherapy with measles–mumps–rubella (MMR) vaccine or vitamin D3 has emerged as an alternative, but their comparative efficacy and safety remain unclear.
Rahul Balach   +9 more
wiley   +1 more source

Meningitis caused by mumps virus in children admitted to Gorgan’s Taleghani hospital

open access: yesMedical Laboratory Journal, 2011
Background and objectives: Mumps virus is one of the first known causative agents of meningitis in children. On-time diagnosis is the first step in treating meningitis.
Moradi AV   +5 more
doaj  

Anticipating Knowledge Applicability in Open Science Through Recycling, Mimicking, and Shortcutting

open access: yesR&D Management, Volume 56, Issue 1, Page 71-87, January 2026.
ABSTRACT Open science literature scrutinizes how organizations provide access to knowledge. Yet, much less is known about how organizations pursuing open science for societal impact anticipate knowledge applicability—that shared knowledge is reusable for other organizations and individuals, and enables open social innovation.
Konstantin Hondros   +3 more
wiley   +1 more source

Mumps Virus: Modification of the Identify-Isolate-Inform Tool for Frontline Healthcare Providers

open access: yesWestern Journal of Emergency Medicine, 2016
Mumps is a highly contagious viral infection that became rare in most industrialized countries following the introduction of measles-mumps-rubella (MMR) vaccine in 1967.
Kristi L. Koenig   +4 more
doaj   +1 more source

High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Background During the period of immunization with a single-dose measles-mumps-rubella (MMR) vaccine, which has been available since 2008in China, the incidence of mumps in children aged 2–5 years has been high.
Xiang Sun   +6 more
doaj   +1 more source

Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization [PDF]

open access: yes, 2009
The current target groups for measles, mumps and rubella vaccination in the Islamic Republic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalence of antibodies against mumps in children aged 3-18 years in Shahrekord
Avijgan, Majid.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy